Cargando…
High-dose budesonide for early COVID-19 – Authors' reply
Autores principales: | Hobbs, F D Richard, Yu, Ly-Mee, Saville, Benjamin R, Bafadhel, Mona, Butler, Christopher C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660058/ https://www.ncbi.nlm.nih.gov/pubmed/34895528 http://dx.doi.org/10.1016/S0140-6736(21)02449-1 |
Ejemplares similares
-
Inhaled budesonide for early treatment of COVID-19 – Authors' reply
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021) -
High-dose budesonide for early COVID-19
por: Lipworth, Brian, et al.
Publicado: (2021) -
High-dose budesonide for early COVID-19
por: Berezowski, Ivan, et al.
Publicado: (2021) -
Inhaled budesonide for early treatment of COVID-19
por: Choi, Jae Chol, et al.
Publicado: (2021) -
Inhaled budesonide for early treatment of COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2021)